MDWD: MediWound Ltd Company Profile & Statistics

About

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel.

Info & Links

CEO

Ofer Gonen

Headquarters

42 HAYARKON STREET
YAVNE, L3 8122745, ISRAEL

Auditor

KPMG International

Share holders

Employees

MediWound Ltd Statistics

Valuation Measures

Market Capitalization²

188.29M

Enterprise Value

184.50M

Enterprise Value/EBITDA(ttm)

-13.44

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

9.46

Price to Book(mrq)

5.45

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

12.52%

Operating Margin(ttm)

-111.35%

Profit Margin(ttm)

-147.32%

Return on Equity(ttm)

-82.17%

Return on Invested Capital(ttm)

-112.77%

Return on Assets(ttm)

-33.67%

Income Statement

Revenue(ttm)

20.14M

Revenue Per Share(ttm)

Gross Profit(ttm)

2.67M

EBITDA(ttm)³

-13.73M

Net Income Available to Common(ttm)

-19.97M

Diluted EPS(ttm)

-2.90

Share Statistics

Beta (5Y Monthly)

0.81

52-Week Change

91.76%

S&P 500 52-Week Change

26.58%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

9.79M

% Held by Insiders

9.20%

% Held by Institutions

46.83%

Balance Sheet

Total Cash(mrq)

29.21M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.11%

Quick Ratio(mrq)

1.99%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-17.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MDWD

MediWound Ltd

MediWound Ltd Profile